U.S. AAA Stent Graft Market Reaching Capacity As Larger Players Weigh In
This article was originally published in The Gray Sheet
Executive Summary
Abdominal aortic aneurysm (AAA) stent graft technology ranks high on the research agendas of several manufacturers this year, with a wave of first and next-generation product launches anticipated
You may also be interested in...
Endomed Plans To Re-Launch AAA Device In Europe, Following MDA Alert
Patient deaths related to Endomed, Inc.'s Endofit endoluminal aortic stent graft resulted from errors made by physicians who did not follow device instructions, the Phoenix-based company maintains
Endomed Plans To Re-Launch AAA Device In Europe, Following MDA Alert
Patient deaths related to Endomed, Inc.'s Endofit endoluminal aortic stent graft resulted from errors made by physicians who did not follow device instructions, the Phoenix-based company maintains
Boston Scientific’s TriVascular Stake Gives AAA Market New Entrant
Boston Scientific's investment in abdominal aortic aneurysm device developer TriVascular, Inc., with an option to buy, shows the company is following through on its promise to become a significant player in the potentially lucrative AAA market